Endometriosis-related PainNCT06286371
Pelvic Neuro-Angiogenesis in Deep Endometriosis
A study testing Laparoscopic Endometriosis Surgery in people with Endometriosis-related Pain and Endometriosis, run by Uludag University at 1 site in Turkey (Türkiye).
Trial summary
Endometriosis is observed in one out of every ten women in society, causing endometrial cells to be found outside their normal location in the body and proliferate in other locations, leading to fibrosis in the tissue due to the secretion of various factors from the cells. Read more about this study
- Who is it for?
- Ages 18 to 45 years, women only
- Conditions the study is for
- Endometriosis-related Pain, Endometriosis, Deep Endometriosis
- What is being tested?
- Laparoscopic Endometriosis Surgery
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 15 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Dec 2023to 31 Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- Women only
- No healthy volunteers
- Adult
Who may be able to join
- Patients with suspicion of deep endometriosis (Physical Examination and MRI)
- Patients with ineffective response to medical therapy
- Patients who undergo laparoscopic conservative endometriosis surgery (douglasectomy)
Who cannot join
- Patients with malignity suspicion
- Patients with extensive surgery (hysterectomy, ovariectomy)
- Patients with previous endometriosis or another pelvic surgery
- Patients with oocyte pick up procedure history
- Patients with pelvic inflammatory disease history
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Uludag University Faculty Hospital
Bursa, Gorukle, 16285
About this study
Official title: Pelvic Neuro-Angiogenesis Density in the Presence of Deep Endometriosis and Relationship Between Pelvic Pain Scores
Endometriosis is observed in one out of every ten women in society, causing endometrial cells to be found outside their normal location in the body and proliferate in other locations, leading to fibrosis in the tissue due to the secretion of various factors from the cells. Additionally, the substances secreted by the cells can cause various other changes in the tissue besides fibrosis. Increased neurogenesis and neovascularization are among the primary changes, which occur as a result of the secretion of substances from the cells. Increased neovascularization, neurogenesis, and fibrosis in the tissue lead to the formation of nodular structures in the pelvic region, resulting in pain development in women.
Nodular formations in the pelvic region due to endometriosis are especially observed in the rectovaginal space. Despite being small in size, they can induce increased neovascularization and neurogenesis even in healthy peritoneal tissue due to the microenvironment they create, leading to different clinical symptoms clinically. However, it is not known how far these changes occur around the endometriotic nodule in the presence of endometriosis.
In this project, in patients operated on due to endometriosis, the density of nerve and vascular structures in the surgical margins of the peritoneal tissue excised along with the nodule, and the synthesis and release of chemical mediators causing pain (e.g., Bradykinin, Substance-P) are evaluated. The aim is to determine the minimum surgical margin where excision should be applied in surgery and to demonstrate any endometriotic changes that may exist in the tissues, even though they may appear macroscopically healthy.
Read the detailed description
This study aims to investigate the relationship between the neurovascular density and the amount of pain mediators present in the excised endometriotic nodule and peritoneal surface during laparoscopic douglasectomy surgery routinely performed in cases of endometriosis unresponsive to medical treatment, and their correlation with pain scores. Together with the findings obtained, the goal is to determine the excision boundaries and surgical safe margins in endometriosis surgery.
Since endometriosis primarily affects the pelvic region, women often encounter various types of chronic pelvic pain, dyspareunia, dysmenorrhea, and dyschezia in daily life depending on the size and location of the nodule, which do not pass frequently. These pains often do not respond to analgesic drugs, and patients experience severe pain attacks. As it is a disease dependent on estrogen in treatment, treatments containing anti-estrogenic and progesterone are primarily applied to suppress the development of endometriosis, while the surgical removal of endometriotic nodules in cases unresponsive to medical treatment provides benefit in terms of pain palliation. In this context, although surgery ideally performed as laparoscopic surgery, peritoneal nodules in the pelvic region are excised together, a procedure called douglasectomy. In many animal experiments, endometriosis nodules have been histopathologically examined, and it has been shown that there is a rich structure in terms of nerve fibers, vascular structure, and pain mediators within the nodule. However, this surgery is a highly specific surgical method and is performed by experienced centers and surgeons. Consequently, the number of patients undergoing ideal surgery is limited. In this limited population, the vascular and neurogenic structure in the peritoneum and nodule surgically removed after douglasectomy, as well as the amount of pain mediators synthesis, remains an unexplored virgin subject. Although increased nerve density within the nodule has been shown in limited studies, the clinical relationship of this density, and its effects on pain scores, has not been investigated in any study on the pathology material removed after douglasectomy operation.
Through the data obtained from this research, the investigators will conclude the histological boundaries of neuro-angiogenic changes occurring in endometriosis disease, the extent of involvement in the pelvic peritoneum, and thus the minimum amount of tissue to be excised during surgery. This result will shed light on a topic that has not been studied in the literature so far and will be a milestone in terms of excision boundaries and surgical safe margins in endometriosis surgery.
This clinical study, approved by the Bursa Uludağ University Faculty of Medicine Clinical Research Ethics Committee with decision number 2023-13/37 on 13.06.2023, will be conducted in the Department of Obstetrics and Gynecology at Bursa Uludağ University Faculty of Medicine. Women of reproductive age who apply to the endometriosis clinic, cannot respond to medical treatment, and are planned for surgery will be included in the study. An average of approximately 150 endometriosis surgeries are performed in our clinic annually. The number of patients to be included in the study was calculated as at least 15 in the power analysis conducted, and the patient recruitment for the study will be completed in a short time in our center, where approximately 150 endometriosis surgeries are performed annually. All demographic data of the patients, preoperative laboratory, and clinical findings will be recorded through files. From the patients who agree to participate in the study, peritoneal tissue samples of 1 cm in size (Figure-1) taken from the pathology specimen removed after the routine surgical procedure will be histopathologically examined, and nerve fibers and vascular structures per square millimeter will be counted after appropriate staining (hematoxylin \& eosin and toluidine blue). In addition, tissue samples preserved under appropriate conditions will be examined for pain mediators (bradykinin, substance P, nerve growth factor, PGP9.5) using the ELISA (Enzyme-Linked ImmunoSorbent Assay) method with kits to be obtained. An average of 10 peritoneal tissue samples will be taken from each patient, and a total of 150 samples will be examined. Each sample will be analyzed twice using the ELISA method, and at least 4 sets of 96 kits will be required for the examination of mediators in 150 separate tissue samples. Results will be analyzed following the commercial ELISA kit protocol. Through the obtained data, the correlation between preoperative pain scores (VAS score - visual pain score) and the neurovascular density within the nodule will be evaluated, and the effects of laparoscopic surgery with nodule excision on pain will be histopathologically demonstrated.
- Being tested
- Laparoscopic Endometriosis Surgery
- Keywords
- Endometriosis, Deep Endometriosis, Pelvic Pain, Neurogenesis, Endometriotic Nodule, Laparoscopy, Endometriosis Surgery
- Medical subject headings
- Endometriosis, Pelvic Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Laparoscopic Endometriosis SurgeryProcedure or surgery
Laparoscopic Excision of Deep Endometriotic Nodule related to pelvic pain
| Study group | Role | What they receive |
|---|---|---|
| Study Group | Experimental | This study has only one group, the group includes patients with laparoscopic endometriosis surgery (douglasectomy). Receives: Procedure: Laparoscopic Endometriosis Surgery |
What is being measured
The primary outcome is the main question the study is designed to answer.
Density of Neuro-Angiogenesis
Density of nerve fibers and capillaries in each 1 cm peritoneal leaf which excised during laparoscopic endometriosis surgery
Measured: 6 months
Density of Pain Mediators in Pelvic Peritoneum
Density of Substance-P, Bradykinin, Nerve Growth Factor and PGP 9.5 in each peritoneal leaf which excised during surgery
Measured: 6 months
Secondary outcomes (1)
Relationship between Neuro-Angiogenesis Density and Pelvic Pain Scores
Patients will be surveyed before and after (0., 3., 6. months) surgery about the visual analogue scores for pelvic pain, and the scores will be analyzed to determine if there is any correlated factor (nerve density, capillary denstiy or pain mediators) with pelvic pain.
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Feb 2024
- Study start1 Dec 2023
- Primary completion23 Apr 2025
- Study completion31 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Endometriosis-related PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 15 participants (actual)
Sponsor and investigators
- Lead sponsor
- Uludag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, GÜRKAN UNCU,PROF. MD, Uludag University
- Investigators
- Gurkan Uncu, Prof., Study chair, Uludag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06286371
- Sponsor's protocol ID
- 2023-13/37
- Status last verified
- Jan 2026
- First submitted
- 22 Feb 2024
- Last updated
- 29 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Aslan K, Cimer E, Mutlu S, Cakir C, Kasapoglu I, Uncu G. Neurovascular Architecture of Deep Endometriosis and Postoperative Pain Outcomes after Butterfly Peritoneal Excision: A Prospective Pilot Study. J Minim Invasive Gynecol. 2026 Jun 7:S1553-4650(26)00295-5. doi: 10.1016/j.jmig.2026.06.002. Online ahead of print.
PubMed 42259471
Study at a glance
From the registry record, last updated by the sponsor on 29 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Pelvic Neuro-Angiogenesis Density in the Presence of Deep Endometriosis and Relationship Between Pelvic Pain Scores
- ClinicalTrials.gov ID
- NCT06286371
- Acronym / sponsor ID
- 2023-13/37
- Keywords
- Endometriosis, Deep Endometriosis, Pelvic Pain, Neurogenesis, Endometriotic Nodule, Laparoscopy, Endometriosis Surgery
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 15 participants (actual)
- Lead sponsor
- Uludag UniversityUniversity, hospital or other
- Study start
- 1 Dec 2023 (actual)
- Primary completion
- 23 Apr 2025 (actual)
- Study completion
- 31 Dec 2025 (actual)
- First posted
- 29 Feb 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Endometriosis is observed in one out of every ten women in society, causing endometrial cells to be found outside their normal location in the body and proliferate in other locations, leading to fibrosis in the tissue due to the secretion of various factors from the cells. Additionally, the substances secreted by the cells can cause various other changes in the tissue besides fibrosis. Increased neurogenesis and neovascularization are among the primary changes, which occur as a result of the secretion of substances from the cells. Increased neovascularization, neurogenesis, and fibrosis in the tissue lead to the formation of nodular structures in the pelvic region, resulting in pain development in women.
Nodular formations in the pelvic region due to endometriosis are especially observed in the rectovaginal space. Despite being small in size, they can induce increased neovascularization and neurogenesis even in healthy peritoneal tissue due to the microenvironment they create, leading to different clinical symptoms clinically. However, it is not known how far these changes occur around the endometriotic nodule in the presence of endometriosis.
In this project, in patients operated on due to endometriosis, the density of nerve and vascular structures in the surgical margins of the peritoneal tissue excised along with the nodule, and the synthesis and release of chemical mediators causing pain (e.g., Bradykinin, Substance-P) are evaluated. The aim is to determine the minimum surgical margin where excision should be applied in surgery and to demonstrate any endometriotic changes that may exist in the tissues, even though they may appear macroscopically healthy.
Detailed description
This study aims to investigate the relationship between the neurovascular density and the amount of pain mediators present in the excised endometriotic nodule and peritoneal surface during laparoscopic douglasectomy surgery routinely performed in cases of endometriosis unresponsive to medical treatment, and their correlation with pain scores. Together with the findings obtained, the goal is to determine the excision boundaries and surgical safe margins in endometriosis surgery.
Since endometriosis primarily affects the pelvic region, women often encounter various types of chronic pelvic pain, dyspareunia, dysmenorrhea, and dyschezia in daily life depending on the size and location of the nodule, which do not pass frequently. These pains often do not respond to analgesic drugs, and patients experience severe pain attacks. As it is a disease dependent on estrogen in treatment, treatments containing anti-estrogenic and progesterone are primarily applied to suppress the development of endometriosis, while the surgical removal of endometriotic nodules in cases unresponsive to medical treatment provides benefit in terms of pain palliation. In this context, although surgery ideally performed as laparoscopic surgery, peritoneal nodules in the pelvic region are excised together, a procedure called douglasectomy. In many animal experiments, endometriosis nodules have been histopathologically examined, and it has been shown that there is a rich structure in terms of nerve fibers, vascular structure, and pain mediators within the nodule. However, this surgery is a highly specific surgical method and is performed by experienced centers and surgeons. Consequently, the number of patients undergoing ideal surgery is limited. In this limited population, the vascular and neurogenic structure in the peritoneum and nodule surgically removed after douglasectomy, as well as the amount of pain mediators synthesis, remains an unexplored virgin subject. Although increased nerve density within the nodule has been shown in limited studies, the clinical relationship of this density, and its effects on pain scores, has not been investigated in any study on the pathology material removed after douglasectomy operation.
Through the data obtained from this research, the investigators will conclude the histological boundaries of neuro-angiogenic changes occurring in endometriosis disease, the extent of involvement in the pelvic peritoneum, and thus the minimum amount of tissue to be excised during surgery. This result will shed light on a topic that has not been studied in the literature so far and will be a milestone in terms of excision boundaries and surgical safe margins in endometriosis surgery.
This clinical study, approved by the Bursa Uludağ University Faculty of Medicine Clinical Research Ethics Committee with decision number 2023-13/37 on 13.06.2023, will be conducted in the Department of Obstetrics and Gynecology at Bursa Uludağ University Faculty of Medicine. Women of reproductive age who apply to the endometriosis clinic, cannot respond to medical treatment, and are planned for surgery will be included in the study. An average of approximately 150 endometriosis surgeries are performed in our clinic annually. The number of patients to be included in the study was calculated as at least 15 in the power analysis conducted, and the patient recruitment for the study will be completed in a short time in our center, where approximately 150 endometriosis surgeries are performed annually. All demographic data of the patients, preoperative laboratory, and clinical findings will be recorded through files. From the patients who agree to participate in the study, peritoneal tissue samples of 1 cm in size (Figure-1) taken from the pathology specimen removed after the routine surgical procedure will be histopathologically examined, and nerve fibers and vascular structures per square millimeter will be counted after appropriate staining (hematoxylin \& eosin and toluidine blue). In addition, tissue samples preserved under appropriate conditions will be examined for pain mediators (bradykinin, substance P, nerve growth factor, PGP9.5) using the ELISA (Enzyme-Linked ImmunoSorbent Assay) method with kits to be obtained. An average of 10 peritoneal tissue samples will be taken from each patient, and a total of 150 samples will be examined. Each sample will be analyzed twice using the ELISA method, and at least 4 sets of 96 kits will be required for the examination of mediators in 150 separate tissue samples. Results will be analyzed following the commercial ELISA kit protocol. Through the obtained data, the correlation between preoperative pain scores (VAS score - visual pain score) and the neurovascular density within the nodule will be evaluated, and the effects of laparoscopic surgery with nodule excision on pain will be histopathologically demonstrated.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Study Group | Experimental | Procedure: Laparoscopic Endometriosis SurgeryThis study has only one group, the group includes patients with laparoscopic endometriosis surgery (douglasectomy). |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Patients with suspicion of deep endometriosis (Physical Examination and MRI)
- Patients with ineffective response to medical therapy
- Patients who undergo laparoscopic conservative endometriosis surgery (douglasectomy)
Key exclusion criteria (5 listed)
- Patients with malignity suspicion
- Patients with extensive surgery (hysterectomy, ovariectomy)
- Patients with previous endometriosis or another pelvic surgery
- Patients with oocyte pick up procedure history
- Patients with pelvic inflammatory disease history
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Laparoscopic Endometriosis SurgeryLaparoscopic Excision of Deep Endometriotic Nodule related to pelvic pain | Procedure or surgery | Study Group |
Primary outcome
Density of Neuro-Angiogenesis
Time frame: 6 months
Density of nerve fibers and capillaries in each 1 cm peritoneal leaf which excised during laparoscopic endometriosis surgery
Density of Pain Mediators in Pelvic Peritoneum
Time frame: 6 months
Density of Substance-P, Bradykinin, Nerve Growth Factor and PGP 9.5 in each peritoneal leaf which excised during surgery
1 secondary outcome
Relationship between Neuro-Angiogenesis Density and Pelvic Pain Scores
Time frame: 6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Jan 2026.
- Derived from this study: PubMed 42259471Aslan K, Cimer E, Mutlu S, Cakir C, Kasapoglu I, Uncu G. Neurovascular Architecture of Deep Endometriosis and Postoperative Pain Outcomes after Butterfly Peritoneal Excision: A Prospective Pilot Study. J Minim Invasive Gynecol. 2026 Jun 7:S1553-4650(26)00295-5. doi: 10.1016/j.jmig.2026.06.002. Online ahead of print.
- Individual participant dataSharing planned: No
Related trials for Endometriosis-related Pain
Not yet recruiting
Effects of Ashwagandha Supplementation on Quality of Life and Well-Being in Women With Endometriosis
Endometriosis, Quality of Life
Active, not recruitingPhase 2
A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis
Endometriosis
RecruitingObservational study
Association of Ultrasound Features of the Myometrium Suggestive of Adenomyosis and Clinical Symptoms
Adenomyosis of Uterus
Recruiting
The Impact of Yoga on Endometriosis-Related Pain
Endometriosis
Recruiting
Functional Links Between the Temporomandibular Joint and the Pelvis in Gynecology
Prolapse; Female, Endometriosis-related Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Gurkan Uncu, Prof. study chair
Uludag University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Laparoscopic Endometriosis Surgery in people with Endometriosis-related Pain and Endometriosis, run by Uludag University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 29 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Density of Neuro-Angiogenesis (time frame: 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06286371, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2026.